Morningstar Downgrades Novartis to Sell

07:29 AM EST, 12/23/2025 (MT Newswires) -- Morningstar on Monday downgraded Swiss drugmaker Novartis (NOVN.SW) to sell from hold and affirmed its price target at 96.00 francs. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)